Clicky

Boston Scientific Corporation(BSX)

Description: Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. The company offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products, such as balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty; intraluminal ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides cardiac rhythm management devices consisting of implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; and implantable pacemaker systems, including implantable cardiac resynchronization therapy pacemaker systems to treat heart failure. In addition, the company offers endoscopy products, such as devices to treat diseases of the digestive and pulmonary systems; and peripheral interventions to diagnose and treat peripheral vascular disease. Further, it provides stone management products comprising ureteral stents, wires, lithotripsy devices, stone retrieval devices, sheaths, balloons, and catheters to treat urinary stone disease and benign prostatic hyperplasia; and mid-urethral sling products, sling materials, graft materials, pelvic floor reconstruction kits, and suturing devices for women's health. Additionally, it provides neuromodulation products used for the management of chronic pain; and medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart, such as radio frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. The company was founded in 1979 and is headquartered in Natick, Massachusetts.


Keywords: Medicine Clinical Medicine S&P 500 Disease Medical Technology Ultrasound Technology Products Catheter Prosthetics Cardiology Heart Failure Chronic Pain Interventional Radiology Endoscopy Cardiac Electrophysiology Protection Devices Artery Benign Prostatic Hyperplasia Ablation Medical Technologies Biomedical Engineering Coronary Artery Disease Artery Disease Interventional Cardiology Neuromodulation Angiography Angioplasty Balloon Catheter Hyperplasia Peripheral Vascular Disease Synchronization Percutaneous Endoscopy Products Cardiac Resynchronization Therapy Neuromodulation Products Artificial Cardiac Pacemaker Embolic Protection Device Lithotripsy Rhythm Disorders

Home Page: www.bostonscientific.com

BSX Technical Analysis

300 Boston Scientific Way
Marlborough, MA 01752-1234
United States
Phone: 508 683 4000


Officers

Name Title
Mr. Michael F. Mahoney Chairman, Pres & CEO
Mr. Daniel J. Brennan Exec. VP & CFO
Mr. Joseph M. Fitzgerald Exec. VP & Group Pres of Cardiology
Mr. Jeffrey B. Mirviss Exec. VP & Pres of Peripheral Interventions
Mr. John Bradley Sorenson Exec. VP of Global Operations
Mr. Jonathan R Monson VP, Global Controller & Chief Accounting Officer
Ms. Jodi Euerle Eddy Sr. VP and Chief Information & Digital Officer
Ms. Susan Vissers Lisa VP of Investor Relations
Mr. Vance R. Brown Sr. VP, Gen. Counsel & Corp. Sec.
Ms. Catherine Jennings VP of Global Marketing & New Bus. Devel. of Peripheral Interventions

Exchange: NYSE

Country: US

Currency: US Dollar ($)

Forward PE: 24.2718
Trailing PE: 111.1951
Price-to-Book MRQ: 3.8306
Price-to-Sales TTM: 5.2793
IPO Date: 1992-05-18
Fiscal Year End: December
Full Time Employees: 41000
Back to stocks